These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 14320330

  • 1. CHANGES OF TRANSPLANTATION CHARACTERISTICS IN METHYLCHOLANTHRENE-INDUCED TUMOURS. ISOLATION OF SPECIFIC ISOANTIGENIC VARIANTS.
    KLEIN J.
    Neoplasma; 1965; 12():125-30. PubMed ID: 14320330
    [No Abstract] [Full Text] [Related]

  • 2. ISOANTIGENIC PROPERTIES OF TUMORS TRANSGRESSING HISTOCOMPATIBILITY BARRIERS OF THE H-2 SYSTEM.
    MOELLER E.
    J Natl Cancer Inst; 1964 Dec; 33():979-89. PubMed ID: 14241790
    [No Abstract] [Full Text] [Related]

  • 3. CHANGES IN THE HOST RANGE OF THE TUMOUR CELL. IMMUNOLOGICAL CHARACTERISTICS OF SPECIFIC ISOANTIGENIC VARIANTS.
    KLEIN J.
    Folia Biol (Praha); 1965 Dec; 11():34-40. PubMed ID: 14281267
    [No Abstract] [Full Text] [Related]

  • 4. STUDIES ON THE MECHANISM OF ISOANTIGENIC VARIANT FORMATION IN HETEROZYGOUS MOUSE TUMORS. III. BEHAVIOR OF H-2 ANTIGENS D AND K WHEN LOCATED IN THE TRANS POSITION.
    KLEIN E, KLEIN G.
    J Natl Cancer Inst; 1964 Mar; 32():569-78. PubMed ID: 14130673
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ISOLATION OF TRANSPLANTATION ISOANTIGENS OF MICE.
    KANDUTSCH AA.
    Methods Med Res; 1964 Mar; 10():70-5. PubMed ID: 14284944
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ABROGATION OF ALLOGENEIC INHIBITION BY CORTISONE.
    HELLSTROEM KE, HELLSTROEM I, HAUGHTON G.
    Science; 1965 Jul 02; 149(3679):82-4. PubMed ID: 14300525
    [Abstract] [Full Text] [Related]

  • 12. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.
    Currie GA, Bagshawe KD.
    Br J Cancer; 1969 Mar 02; 23(1):141-9. PubMed ID: 5768430
    [No Abstract] [Full Text] [Related]

  • 13. AUTOLOGOUS AND HOMOLOGOUS TUMOR TRANSPLANTATION IN ANIMALS BEARING METHYLCHOLANTHRENE-INDUCED SARCOMA.
    MATSUYAMA M.
    Gan; 1964 Jun 02; 55():237-43. PubMed ID: 14188567
    [No Abstract] [Full Text] [Related]

  • 14. ANTIGENICITY OF A CRUDE LIPOPOLYSACCHARIDE FRACTION OF THE METHYLCHOLANTHRENE-INDUCED TUMOR, WITH SPECIAL REFERENCE TO ISOLOGOUS IMMUNITY IN INBRED RATS.
    MATSUMOTO T.
    Gan; 1965 Feb 02; 56():1-11. PubMed ID: 14326031
    [No Abstract] [Full Text] [Related]

  • 15. IMMUNOLOGICAL PROPERTIES OF CHEMICALLY INDUCED SARCOMAS.
    FELDMAN M, GLOBERSON A, YAFFE D.
    Philipp J Cancer; 1963 Feb 02; 5():562-73. PubMed ID: 14232632
    [No Abstract] [Full Text] [Related]

  • 16. IMMUNITY AGAINST CANCEROGEN-INDUCED TUMOURS.
    BUBENIK J.
    Neoplasma; 1965 Feb 02; 12():119-24. PubMed ID: 14320329
    [No Abstract] [Full Text] [Related]

  • 17. Tumor-associated antigens in isoantigenic variants of a 3-methylcholanthrene-induced sarcoma.
    Oth D, Berebbi M, Meyer G.
    J Natl Cancer Inst; 1975 Oct 02; 55(4):903-8. PubMed ID: 52721
    [Abstract] [Full Text] [Related]

  • 18. RELATIONSHIP BETWEEN HOST RANGE AND ISOANTIGENIC PROPERTIES IN DIFFERENT SUBLINES OF THE SAME SARCOMA.
    KLEIN E, MULLER E.
    J Natl Cancer Inst; 1963 Aug 02; 31():347-64. PubMed ID: 14046629
    [No Abstract] [Full Text] [Related]

  • 19. ATTEMPTS TO FIND CELL ASSOCIATED IMMUNE REACTION AGAINST AUTOCHTHONOUS TUMORS.
    YOSHIDA TO, SOUTHAM CM.
    Jpn J Exp Med; 1963 Dec 02; 33():369-83. PubMed ID: 14148095
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.